NEW YORK (360Dx) – Molecular diagnostics company iCubate today announced the US Food and Drug Administration has cleared its iC-System and iC-GPC assay for the rapid detection of pathogenic bacteria associated with bloodstream infections.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.